A recent study examining trends in the discard of kidneys from deceased donors with hepatitis C virus (HCV) viremia showed equivalent use of kidneys from HCV aviremic seropositive and HCV aviremic seronegative donors in 2018 and 2019.
NVX-CoV2373 is engineered from the genetic sequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the Company’s recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein.
Patients hospitalized with COVID-19 who have a history of heart failure were found to have greater mortality risk.
A study revealed a nearly 25% rate of all-cause mortality among patients on maintenance dialysis who contract COVID-19.
Risk for death reduced with higher versus lower levels of anti-SARS-CoV-2 IgG, but only in patients not receiving mechanical ventilation
Strong motivation often provides the push to translate investigational technologies into real-world clinical use. Case in point: messenger RNA vaccines.
In nursing homes and to some degree in hospitals, employees are refusing shots, expressing fears of side effects
Five cases of euDKA identified in patients with type 2 diabetes using SGLT2 inhibitors who developed SARS-CoV-2 infection.
Less than 1% of patients receiving antitumor treatment between Jan. 15 and May 4, 2020, developed COVID-19
Risk for severe COVID-19 similar among those with type 1 and type 2 diabetes
